help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malaisse, W. J.
Right arrow Articles by Malaisse-Lagae, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malaisse, W. J.
Right arrow Articles by Malaisse-Lagae, F.

Endocrinology, Vol 113, 1870-1877, Copyright © 1983 by Endocrine Society

ARTICLES

Synergistic effect of a tumor-promoting phorbol ester and a hypoglycemic sulfonylurea upon insulin release

WJ Malaisse, P Lebrun, A Herchuelz, A Sener and F Malaisse-Lagae

The tumor-promoting phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and the hypoglycemic sulfonylurea gliclazide both stimulate insulin release from rat pancreatic islets incubated at a low concentration of glucose (2.8 mM). The increment in secretion rate evoked by the combination of these two secretagogues was at least 7 times higher than the sum of increments evoked by each agent alone. TPA augmented insulin release evoked by gliclazide more efficiently than that induced by glucose. The enhancing action of TPA could not be attributed solely to changes in the capacity of gliclazide to inhibit 86Rb outflow, to provoke an exchange between influent 40Ca and effluent 45Ca, or to stimulate the net uptake of 45Ca by the islets. Nevertheless, the facilitation by TPA of gliclazide-induced insulin release suggests that a biophysical interference with the handling of cations at the plasma membrane level represents the primary site of action of hypoglycemic sulfonylureas in the pancreatic B cell.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
W. S. Zawalich, K. C. Zawalich, G. J. Tesz, J. A. Sterpka, and W. M. Philbrick
Insulin secretion and IP levels in two distant lineages of the genus Mus: comparisons with rat islets
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E720 - E728.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society